tiprankstipranks
Roivant Sciences (ROIV)
NASDAQ:ROIV
US Market
ROIV
Roivant Sciences
RESEARCH TOOLSreports

Roivant Sciences (ROIV) Stock News & Sentiment

711 Followers
Roivant Advances Brepocitinib Program, Refocuses Autoimmune Portfolio
Premium
Company Announcements
Roivant Advances Brepocitinib Program, Refocuses Autoimmune Portfolio
8d ago
8K
ROIV
Unlocking Value from IP Settlement and Pipeline Catalysts: Why Roivant Deserves a Buy Rating
Premium
Ratings
Unlocking Value from IP Settlement and Pipeline Catalysts: Why Roivant Deserves a Buy Rating
1M ago
ROIV
Roivant: Strengthened Cash Position Post‑Moderna Settlement but Limited Upside Keeps Rating at Hold
Premium
Ratings
Roivant: Strengthened Cash Position Post‑Moderna Settlement but Limited Upside Keeps Rating at Hold
1M ago
ROIV
Roivant Subsidiary Reaches Major Global Patent Settlement
Premium
Company Announcements
Roivant Subsidiary Reaches Major Global Patent Settlement
1M ago
8K
ROIV
Roivant’s Priovant Unit Gains FDA Priority Review for Brepocitinib
Premium
Company Announcements
Roivant’s Priovant Unit Gains FDA Priority Review for Brepocitinib
1M ago
8K
ROIV
Roivant Sciences Earnings Call Highlights Brepocitinib Surge
Premium
Company Announcements
Roivant Sciences Earnings Call Highlights Brepocitinib Surge
2M ago
ROIV
ROIV Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
ROIV Earnings this Week: How Will it Perform?
2M ago
ROIV
More ROIV News >

ROIV News on the Web

Analysts Are Bullish on Top Healthcare Stocks: Roivant Sciences (ROIV), Boston Scientific (BSX)
TipRanks News
Neutral
Roivant Sciences price target raised to $34 from $30 at Jefferies
TipRanks News
Neutral
Roivant Sciences Stock Sinks After Drug Trial Failure
TipRanks News
Bearish
Roivant Sciences Stock Tumbles After Key Drug Setback
TipRanks News
Neutral
Roivant Sciences Stock Slumps After Trial Letdown
TipRanks News
Bearish
Why Roivant Sciences Stock Is Sinking Today
TipRanks News
Bearish
Roivant Sciences Ltd Brepocitinib Program Expansion and Batoclimab Update Transcript
GuruFocus News
Neutral
Roivant Advances Brepocitinib Program, Refocuses Autoimmune Portfolio
TipRanks News
Neutral

News Score - Last 7 Days

Very Negative
ROIV
Sector Average
Media Buzz
This Week6 articles
Weekly Average4 articles
News Sentiment
This Week0%
Sector Average69%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is ROIV’s Media Buzz Sentiment?
6 articles about ROIV were published this week. In an average week, 4 articles are published.
    What is ROIV’s weekly average amount of articles?
    In an average week, 4 articles about ROIV are published.
      What is ROIV’s News Sentiment?
      Currently, no data Available
      Healthcare Stocks that are Trending in the News
      NBIXNeurocrine
      AORTArtivion
      OWLTOwlet
      STAAStaar Surgical
      HUMHumana
      Showing the stocks with the most bullish news sentiment over the past week